Remedium Research 30mg Retatrutide FlexiPen

Remedium Research 30mg Retatrutide FlexiPen, Triple-Agonist Research Peptide

Retatrutide is a next-generation triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. This multi-receptor approach delivers superior metabolic effects compared to single or dual-agonist compounds.

How Retatrutide Works

In preclinical studies, activation of GLP-1 and GIP receptors has been associated with increased insulin secretion, reduced glucagon production, slowed gastric emptying, and reduced appetite. Stimulation of glucagon receptors has been linked to increased energy expenditure and activation of fat oxidation processes.

What's Included

Each box contains:

• 1x Prefilled FlexiPen (30mg Retatrutide)
• 20x Sterile Pen Needles

Composition

Water for injection, sodium chloride, trehalose, disodium phosphate dihydrate, methionine, m-cresol, and sodium hydroxide. Stabilized and pH balanced solution for subcutaneous injection.

Storage

Store at +2 to +8°C. Maintain cold chain at all times. Do not freeze.

Quality Assurance

Every batch is independently tested by Janoshik Analytical to verified ≥99.2% HPLC purity. Third-party test results are published and available on our Test Results page.